Literature DB >> 18629634

Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.

Giuseppe Viale1, Nicole Rotmensz, Patrick Maisonneuve, Enrico Orvieto, Eugenio Maiorano, Viviana Galimberti, Alberto Luini, Marco Colleoni, Aron Goldhirsch, Alan S Coates.   

Abstract

Whether invasive lobular carcinoma of the breast per se constitutes a prognostically favorable type has been debated. The present series comprises 301 consecutive "classic" lobular breast carcinomas seen at one institution between 1994 and 2001, compared to an equal number of invasive ductal carcinomas at the same institution during the same period, matched for year of surgery, age, menopausal status, primary tumor size, nodal involvement, hormone receptor status and where possible histological grade. Despite matching, the lobular carcinomas were more frequently multifocal, had more involved nodes, lower grade and lower proliferative fraction. There was no significant difference in disease-free or overall survival, locoregional relapse or time to distant metastasis between the lobular and ductal groups overall or within any examined subset, though the lobular group showed a trend to earlier appearance of contralateral breast cancer. Classical lobular histology is not an independent factor in the prognosis of early breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18629634     DOI: 10.1007/s10549-008-0112-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  Risk of mortality by histologic type of breast cancer in the United States.

Authors:  Christopher I Li
Journal:  Horm Cancer       Date:  2010-06       Impact factor: 3.869

Review 2.  Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.

Authors:  Nuket Eliyatkın; Evrim Yalçın; Baha Zengel; Safiye Aktaş; Enver Vardar
Journal:  J Breast Health       Date:  2015-04-01

3.  Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.

Authors:  Yu Zhang; Xiulan Luo; Min Chen; Libo Yang; Ting Lei; Tianjie Pu; Bing Wei; Hong Bu; Zhang Zhang
Journal:  Breast Cancer Res Treat       Date:  2022-06-06       Impact factor: 4.872

4.  Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.

Authors:  Natalya Khilko; Jianmin Wang; Bing Wei; David G Hicks; Ping Tang
Journal:  Breast Cancer (Auckl)       Date:  2010-10-21

5.  A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma.

Authors:  Nüvit Duraker; Semih Hot; Arzu Akan; Pınar Özay Nayır
Journal:  Eur J Breast Health       Date:  2020-01-01

6.  t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.

Authors:  Bhavatarini Vangamudi; Dun-Fa Peng; Qiuyin Cai; Wael El-Rifai; Wei Zheng; Abbes Belkhiri
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

7.  Molecular Classification of Lobular Carcinoma of the Breast.

Authors:  Denggang Fu; Qi Zuo; Qi Huang; Li Su; Huijun Z Ring; Brian Z Ring
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

8.  ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.

Authors:  Gabrielle Deniziaut; Jean Christophe Tille; François-Clément Bidard; Sophie Vacher; Anne Schnitzler; Walid Chemlali; Laurence Trémoulet; Laetitia Fuhrmann; Paul Cottu; Roman Rouzier; Ivan Bièche; Anne Vincent-Salomon
Journal:  Oncotarget       Date:  2016-11-08

Review 9.  Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.

Authors:  Amy E McCart Reed; Lauren Kalinowski; Peter T Simpson; Sunil R Lakhani
Journal:  Breast Cancer Res       Date:  2021-01-07       Impact factor: 6.466

10.  Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.

Authors:  Nadine Norton; Pooja P Advani; Daniel J Serie; Xochiquetzal J Geiger; Brian M Necela; Bianca C Axenfeld; Jennifer M Kachergus; Ryan W Feathers; Jennifer M Carr; Julia E Crook; Alvaro Moreno-Aspitia; Panos Z Anastasiadis; Edith A Perez; E Aubrey Thompson
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.